These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 32081490)

  • 41. A BAP1 mutation in a Danish family predisposes to uveal melanoma and other cancers.
    Aoude LG; Wadt K; Bojesen A; Crüger D; Borg A; Trent JM; Brown KM; Gerdes AM; Jönsson G; Hayward NK
    PLoS One; 2013; 8(8):e72144. PubMed ID: 23977234
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bioinformatics analysis of GNAQ, GNA11, BAP1, SF3B1,SRSF2, EIF1AX, PLCB4, and CYSLTR2 genes and their role in the pathogenesis of Uveal Melanoma.
    Akin-Bali DF
    Ophthalmic Genet; 2021 Dec; 42(6):732-743. PubMed ID: 34353217
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intraocular Metastasis in Unilateral Multifocal Uveal Melanoma Without Melanocytosis or Germline BAP1 Mutations.
    Durante MA; Walter SD; Paez-Escamilla M; Tokarev J; Decatur CL; Dubovy SR; Schefler AC; Harbour JW
    JAMA Ophthalmol; 2019 Dec; 137(12):1434-1439. PubMed ID: 31580399
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The genetic basis of uveal melanoma.
    Nielsen M; Dogrusöz M; Bleeker JC; Kroes WG; van Asperen CA; Marinkovic M; Luyten GP; Jager MJ
    J Fr Ophtalmol; 2015 Jun; 38(6):516-21. PubMed ID: 25976137
    [TBL] [Abstract][Full Text] [Related]  

  • 45. BAP1 Loss Is Associated with DNA Methylomic Repatterning in Highly Aggressive Class 2 Uveal Melanomas.
    Field MG; Kuznetsov JN; Bussies PL; Cai LZ; Alawa KA; Decatur CL; Kurtenbach S; Harbour JW
    Clin Cancer Res; 2019 Sep; 25(18):5663-5673. PubMed ID: 31285370
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutational landscape in Uveal Melanoma.
    Mastronikolis S; Adamopoulou M; Papouliakos S; Manoli A; Katsinis S; Makri O; Monastirioti AE; Tsiambas E; Georgakopoulos C
    J BUON; 2021; 26(4):1194-1197. PubMed ID: 34564968
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparing the Prognostic Value of BAP1 Mutation Pattern, Chromosome 3 Status, and BAP1 Immunohistochemistry in Uveal Melanoma.
    van de Nes JA; Nelles J; Kreis S; Metz CH; Hager T; Lohmann DR; Zeschnigk M
    Am J Surg Pathol; 2016 Jun; 40(6):796-805. PubMed ID: 27015033
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of germline BAP1 mutation in a population-based sample of uveal melanoma cases.
    Aoude LG; Vajdic CM; Kricker A; Armstrong B; Hayward NK
    Pigment Cell Melanoma Res; 2013 Mar; 26(2):278-9. PubMed ID: 23171164
    [No Abstract]   [Full Text] [Related]  

  • 49. Uveal Melanoma Nuclear BRCA1-Associated Protein-1 Immunoreactivity Is an Indicator of Metastasis.
    Szalai E; Wells JR; Ward L; Grossniklaus HE
    Ophthalmology; 2018 Feb; 125(2):203-209. PubMed ID: 28823399
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma.
    Koopmans AE; Verdijk RM; Brouwer RW; van den Bosch TP; van den Berg MM; Vaarwater J; Kockx CE; Paridaens D; Naus NC; Nellist M; van IJcken WF; Kiliç E; de Klein A
    Mod Pathol; 2014 Oct; 27(10):1321-30. PubMed ID: 24633195
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of somatic mutations and chromosomal aberrations in the prognosis of uveal melanoma in a Spanish patient cohort.
    Silva-Rodríguez P; Bande M; Fernández-Díaz D; Lago-Baameiro N; Pardo M; José Blanco-Teijeiro M; Domínguez F; Loidi L; Piñeiro A
    Acta Ophthalmol; 2021 Nov; 99(7):e1077-e1089. PubMed ID: 33421325
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
    Couch FJ; Shimelis H; Hu C; Hart SN; Polley EC; Na J; Hallberg E; Moore R; Thomas A; Lilyquist J; Feng B; McFarland R; Pesaran T; Huether R; LaDuca H; Chao EC; Goldgar DE; Dolinsky JS
    JAMA Oncol; 2017 Sep; 3(9):1190-1196. PubMed ID: 28418444
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic Background of Iris Melanomas and Iris Melanocytic Tumors of Uncertain Malignant Potential.
    van Poppelen NM; Vaarwater J; Mudhar HS; Sisley K; Rennie IG; Rundle P; Brands T; van den Bosch QCC; Mensink HW; de Klein A; Kiliç E; Verdijk RM
    Ophthalmology; 2018 Jun; 125(6):904-912. PubMed ID: 29371009
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genomic, prognostic, and cell-signaling advances in uveal melanoma.
    Harbour JW
    Am Soc Clin Oncol Educ Book; 2013; ():388-91. PubMed ID: 23714557
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical Implications of Real-time Integrative Sequencing in Management of Patients With Suspected Germline BAP1 Mutations.
    Sengupta S; Weyand AC; Upadhyaya SA; Wu YM; Robinson DR; Mody RJ
    J Pediatr Hematol Oncol; 2019 May; 41(4):e263-e265. PubMed ID: 29554022
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transposase mapping identifies the genomic targets of BAP1 in uveal melanoma.
    Yen M; Qi Z; Chen X; Cooper JA; Mitra RD; Onken MD
    BMC Med Genomics; 2018 Nov; 11(1):97. PubMed ID: 30400891
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chromosomal rearrangements in uveal melanoma: Chromothripsis.
    van Poppelen NM; Yavuzyigitoglu S; Smit KN; Vaarwater J; Eussen B; Brands T; Paridaens D; Kiliç E; de Klein A
    Genes Chromosomes Cancer; 2018 Sep; 57(9):452-458. PubMed ID: 29726589
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer.
    Yurgelun MB; Chittenden AB; Morales-Oyarvide V; Rubinson DA; Dunne RF; Kozak MM; Qian ZR; Welch MW; Brais LK; Da Silva A; Bui JL; Yuan C; Li T; Li W; Masuda A; Gu M; Bullock AJ; Chang DT; Clancy TE; Linehan DC; Findeis-Hosey JJ; Doyle LA; Thorner AR; Ducar MD; Wollison BM; Khalaf N; Perez K; Syngal S; Aguirre AJ; Hahn WC; Meyerson ML; Fuchs CS; Ogino S; Hornick JL; Hezel AF; Koong AC; Nowak JA; Wolpin BM
    Genet Med; 2019 Jan; 21(1):213-223. PubMed ID: 29961768
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma.
    Betti M; Aspesi A; Biasi A; Casalone E; Ferrante D; Ogliara P; Gironi LC; Giorgione R; Farinelli P; Grosso F; Libener R; Rosato S; Turchetti D; Maffè A; Casadio C; Ascoli V; Dianzani C; Colombo E; Piccolini E; Pavesi M; Miccoli S; Mirabelli D; Bracco C; Righi L; Boldorini R; Papotti M; Matullo G; Magnani C; Pasini B; Dianzani I
    Cancer Lett; 2016 Aug; 378(2):120-30. PubMed ID: 27181379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.